Sleep Care Explained
Getting evaluated and treated for a sleep disorder means moving through a small ecosystem of different entities — clinics, labs, equipment suppliers, monitoring services — and figuring out who pays for what. The vocabulary is confusing partly because the terms overlap and partly because the same word can mean different things in different health systems. This page explains the service roles you’ll encounter and the payment pathways that typically apply, in plain language. It is a structural map, not benefits advice: the goal is to help you understand the landscape well enough to ask the right questions of your own clinician and insurer.
Why sleep care feels more complicated than it should
Most medical care happens in a fairly legible setting: you see a doctor in an office, you get a test at a hospital or lab, you fill a prescription at a pharmacy. Sleep care is structured differently enough that it routinely confuses people who are otherwise comfortable navigating healthcare. There are a few reasons for this.
First, the diagnostic step often happens outside a conventional clinical setting — sometimes in a dedicated overnight facility, sometimes in the patient’s own bedroom with a device mailed to the door. Second, the treatment for the most common sleep disorder, obstructive sleep apnea, is not a pill but a piece of equipment that the patient owns, maintains, and uses every night for years — which pulls in a category of supplier most patients have never dealt with. Third, the entities involved frequently have similar-sounding names (“sleep center,” “sleep clinic,” “sleep lab,” “sleep institute”) that are used loosely and inconsistently across the industry.
The practical consequence is that a patient can finish a sleep evaluation without ever being entirely sure who they just dealt with or why a particular bill arrived. This page breaks the ecosystem into two questions that are genuinely separate even though they’re often tangled together: who does what (the service roles), and who pays for it (the payment pathways). Understanding them separately makes the whole thing far easier to follow.
Sleep clinic versus sleep lab — they’re not the same thing
The single most useful distinction to internalize is the difference between a sleep clinic and a sleep lab. They are different functions, even when they share a building, a brand, or a parent organization.
A sleep clinic (also called a sleep medicine clinic or sleep center, in its clinical sense) is a clinical-care entity. It is where you see a clinician — typically a board-certified sleep medicine physician, sometimes a nurse practitioner or physician assistant working under one. The clinic is where evaluation, diagnosis, treatment decisions, and follow-up happen. The clinic interprets test results, prescribes therapy, manages your care over time, and coordinates with your other doctors. If you have a relationship with “a sleep doctor,” the clinic is the entity that relationship lives in.
A sleep lab (also called a sleep laboratory or, more formally, a sleep testing facility) is a testing facility. Its job is to run the overnight study — the in-lab polysomnogram described on the in-lab sleep study page — and produce the raw physiological recording. The lab is staffed by sleep technologists who set up sensors, monitor the recording through the night, and score the data. The lab does not, in its lab capacity, diagnose you or prescribe treatment; it generates the data that a clinic’s physician then interprets.
In practice these two functions are frequently co-located and integrated — a single accredited sleep center may contain both the clinic where you’re seen and the lab where you’re tested, and the physician who interprets your study may be the same one who manages your care. That integration is convenient and common. But the distinction still matters, because:
- They can be billed separately. A clinic visit (an evaluation-and-management service) and a sleep study (a diagnostic test) are different billable services, often with different coverage rules and different out-of-pocket exposure. Two line items from one visit can confuse patients who assumed “the sleep place” was one charge.
- They can be physically separate. Your clinic might order a study performed at a partner lab across town, or order a home test that involves no lab at all. The clinician you see and the facility you’re tested at need not be the same organization.
- Accreditation applies to both, distinctly. Programs such as American Academy of Sleep Medicine (AASM) accreditation and Joint Commission accreditation set standards for testing facilities and for clinical programs. A facility advertising accreditation is making a specific claim worth understanding — see the accreditation note later on this page.
The reason to keep clinic and lab mentally separate is that it answers the recurring patient question: “I got tested — why am I being asked to come back in?” The answer is almost always that the lab did its job (produced the recording) and now the clinic needs to do its job (interpret it with you and decide what happens next). Diagnosis and treatment live with the clinic, not the lab.
Where testing actually happens
Sleep apnea testing — the most common reason for a sleep evaluation — happens in one of two settings, and which one applies shapes the rest of the experience.
In a sleep lab. An in-lab polysomnogram is the comprehensive overnight study: the patient sleeps at the facility while a technologist records a full panel of physiological channels — brain activity, eye movement, muscle tone, airflow, respiratory effort, oxygen, and heart rhythm. This is the diagnostic gold standard and the appropriate test for complex cases, children, and suspected non-apnea sleep disorders.
At home. A home sleep apnea test (HST) is a portable device the patient uses in their own bed for one or more nights, recording a narrower set of respiratory channels. For the right patient — an adult with a high pretest probability of uncomplicated moderate-to-severe obstructive sleep apnea — it’s a faster, lower-cost, more comfortable path to a diagnosis. It is not appropriate for every situation, and a negative home test in a high-suspicion patient typically escalates to an in-lab study.
The decision between the two is clinical, made by the ordering physician based on pretest probability and the patient’s profile. Both pages linked above cover the criteria in depth. The relevant point for understanding the ecosystem is that a home test may involve no sleep lab at all — the device might be shipped to your home and the recording scored remotely — which is one more reason the “clinic versus lab” distinction matters: with a home test, you may interact only with a clinic and a device, never setting foot in a testing facility.
Remote monitoring and durable medical equipment
Two more service roles appear once a diagnosis leads to treatment, and they’re the ones patients are least prepared for because they have no equivalent in most other areas of medicine.
Durable medical equipment (DME) is the category that covers the physical equipment used to treat a sleep disorder — most commonly the CPAP machine, its mask, tubing, humidifier chamber, and the consumable supplies (filters, cushions, headgear) that are replaced on a schedule. “Durable medical equipment” is a formal insurance and regulatory category, not a brand or a specific store: it refers to medically necessary equipment intended for repeated use over time, prescribed by a clinician and supplied by a DME supplier. The supplier is the entity that dispenses the machine, handles the insurance paperwork for the equipment, manages resupply of consumables, and is often the patient’s first point of contact for device troubleshooting. A patient diagnosed with sleep apnea is therefore frequently dealing with three distinct entities: the clinic (the physician who diagnoses and prescribes), the lab or home-test pathway (the diagnosis), and the DME supplier (the equipment). These can be integrated under one organization or entirely separate vendors, which is why the equipment bill sometimes comes from a name the patient doesn’t recognize.
DME matters to patients for a few concrete reasons. Insurance coverage of CPAP equipment is frequently conditional on documented use — many plans require evidence that the patient is using the device for a minimum number of hours on a minimum number of nights during an initial compliance period before they’ll continue covering it. The equipment also generates an ongoing resupply relationship rather than a one-time purchase, because masks and filters wear out and are replaced on a schedule. And the equipment can be obtained through insurance or purchased outright as a cash transaction, which interacts with the payment pathways discussed below.
Remote patient monitoring (RPM) is the service role that has grown alongside modern CPAP equipment. Most current CPAP machines are connected devices: they record nightly usage, mask-fit and leak data, and the residual apnea events the therapy isn’t catching, then transmit that data to the clinic and the DME supplier. RPM is the practice of a care team reviewing that streamed data to confirm the therapy is working, troubleshoot problems remotely, and intervene early when usage drops or the numbers drift. For the patient, RPM is the reason a clinic might call to check in without an office visit, or adjust therapy based on data the machine reported on its own. It’s also the mechanism behind the compliance documentation that insurers often require. RPM is a clinical service that can be billed as such, which is one more potential line item in the ecosystem — and one more reason to understand that “sleep care” is a set of distinct services rather than a single transaction.
How sleep care is paid for
The payment side of sleep care is the part most tilted toward a specific country’s rules — the concrete programs differ everywhere — but the structural categories translate across systems. The examples below are US programs used to illustrate categories that have analogues in most health systems; readers elsewhere can map them onto their own coverage.
Two structural questions govern almost every sleep-care payment situation: (1) is this being billed to a third-party payer (insurance) or paid directly by the patient (cash pay)? and (2) does the service require pre-approval before it happens? Everything else is detail layered on top of those two axes.
Insurance (third-party coverage). In most situations, sleep evaluations, tests, and equipment are billed to a health insurer — a private commercial plan, an employer-sponsored plan, or a public program. The defining feature of insurance is that a third party pays some or all of the cost according to a coverage policy, and the patient is responsible for the remainder (deductibles, copayments, coinsurance). Coverage of sleep services is generally well established — sleep apnea is a recognized medical condition with clear diagnostic criteria — but the specifics of what’s covered, at what facility, and after what approvals vary by plan.
Cash pay (self-pay). The alternative is paying directly, outside of insurance. Patients choose cash pay for several reasons: they may be uninsured; their plan may not cover a particular service or provider; the cash price may be lower than their deductible exposure; or they may want to skip the prior-authorization process and its delays. Cash-pay pricing is common for home sleep tests, for CPAP equipment purchased outright, and for newer membership-style sleep and wellness services. Cash pay trades the cost-sharing benefit of insurance for speed, simplicity, and provider choice.
Public coverage programs. In the US, Medicare (primarily for people 65 and older and certain younger people with disabilities) and Medicaid (income-based coverage administered by states) are the major public programs. They set their own coverage rules for sleep testing and equipment — Medicare’s coverage criteria for CPAP, for instance, are widely used as a reference point across the industry. Most countries have a public-coverage analogue (a national health service, a public insurer, or a hybrid), and the structural role is the same: a government program defines what it will cover and under what conditions.
Tax-advantaged accounts. In the US, Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) let patients set aside pre-tax money for qualified medical expenses. Sleep testing, CPAP equipment, and many related supplies are typically eligible. These accounts don’t pay instead of insurance or cash — they’re a tax-advantaged way to fund the patient’s share of either. Many countries have comparable tax-advantaged medical-spending mechanisms; the structural idea is the same even where the specific account type differs.
Prior authorization, medical necessity, and the paper trail
The second structural question — does the service require pre-approval — deserves its own section, because the documentation requirements around sleep care surprise more patients than anything else.
Prior authorization is the process by which an insurer approves a service before it’s provided. Many plans require prior authorization for an in-lab sleep study, for CPAP equipment, and sometimes for the initial specialist consultation. The clinician’s office typically handles the paperwork, but the requirement is why a test that’s clinically ready to go can still be days or weeks out — the approval has to clear first. Cash pay sidesteps prior authorization entirely, which is one of its main appeals for patients who want to move quickly.
Medical necessity is the standard most coverage decisions turn on. An insurer will generally cover a sleep study or CPAP equipment when there’s documented clinical justification — symptoms, screening scores, and a clinician’s assessment establishing that the test or treatment is appropriate. This is why the screening step matters administratively as well as clinically: a documented high pretest probability supports the medical-necessity case for the test that follows.
The compliance trail. CPAP coverage is the clearest example of documentation that continues after treatment begins. Because connected machines report usage data (the RPM mechanism described above), many insurers condition continued coverage on demonstrated use during an initial period. A patient who is prescribed CPAP but doesn’t use it enough during that window can find coverage discontinued — not as a penalty, but because the coverage policy requires evidence the equipment is being used as intended. Understanding this up front helps patients treat the early weeks of therapy as the consequential period they are, both clinically and administratively.
None of this is advice about any individual’s coverage. Plans differ, programs change, and the only authoritative source for what applies to a given patient is that patient’s own insurer and clinician. The point here is structural: knowing that prior authorization, medical-necessity documentation, and a post-treatment compliance trail are features of the system lets a patient anticipate them rather than be blindsided.
Putting the ecosystem together
Pulling the service roles and payment pathways into a single view, here’s how a typical sleep apnea journey moves through the ecosystem:
In more detail, with the relevant cross-references:
- Recognition and screening. Symptoms surface, and a clinician — often a primary care physician — assesses pretest probability using validated tools. The free Sleep Score screener is one starting point patients can use before that conversation.
- The clinic. A sleep medicine clinic (or a primary care physician, in many systems) orders the appropriate diagnostic test. This is the clinical-care entity that will own the diagnosis and treatment decisions.
- The test. Diagnosis happens either at a sleep lab (in-lab polysomnogram) or via a home sleep apnea test, depending on the clinical picture. The lab generates data; the clinic interprets it.
- The equipment. If the diagnosis leads to CPAP, a DME supplier dispenses the machine and supplies and manages ongoing resupply. This may be the same organization as the clinic or a separate vendor.
- Ongoing monitoring. Remote patient monitoring lets the care team confirm the therapy is working and intervene when it isn’t, using data the connected device reports automatically.
- Payment, throughout. Each step is billed to insurance or paid in cash, may require prior authorization, and rests on medical-necessity documentation — with CPAP coverage often conditioned on a post-treatment compliance trail.
The single most useful habit a patient can build from all of this is to ask, at each step, two questions: which entity am I dealing with right now — clinic, lab, or supplier — and how is this particular service being paid for. Those two questions cut through almost all of the confusion, because they separate the “who does what” axis from the “who pays” axis that the industry’s loose terminology tends to blur together.
A brief note on accreditation, which threads through the whole ecosystem: independent accreditation programs — AASM accreditation for sleep facilities, Joint Commission accreditation for broader clinical programs — set and verify quality standards for testing and care. When a sleep center advertises accreditation, it is making a specific, verifiable claim about meeting those standards. It’s a reasonable thing to ask about and confirm, particularly for the diagnostic step, where signal quality and interpretation depend on the facility doing things to standard. If you want help locating an accredited sleep specialist near you, the city directory is a starting point.
Frequently asked questions
What’s the difference between a sleep clinic and a sleep lab?
What is DME, and why am I getting a separate bill for my CPAP?
Do I need insurance to get a sleep test?
Why does my insurance want proof that I’m using my CPAP?
Can I use my HSA or FSA to pay for sleep testing or a CPAP?
What does it mean when a sleep center is accredited?
Talk to a board-certified sleep specialist near you.